Advertisement

Advancing EUA IVD Products Toward Full Marketing Status

FDA White Oak Campus 10903 New Hampshire Ave, Silver Spring, MD, United States

The Medical Device Innovation Consortium (MDIC) will host a workshop on 3 Feb 2020 to explore key considerations for using real world data to help support in vitro diagnostic (IVD) products available under FDA’s emergency use authorization (EUA) to advance to full marketing status. A roadmap for diagnostic evaluations during emergencies would help enable stakeholders

CDC National Call Series on Novel Coronavirus Monitoring & Preparedness

The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national

Yale Forum on Outbreak of Novel Coronavirus

Winslow Auditorium 60 College Street, LEPH 109, New Haven, CT, United States

In response to news and concerns about the respiratory illness outbreak caused by a novel coronavirus initially identified in China, the Yale Institute for Global Health, Yale School of Public Health and the Global Health Justice Partnership will hold a discussion and question and answer session on Thursday, February 6, 2020. Panelists will address the

Containing the Coronavirus: Challenges to Thwarting the Outbreak

Hudson Institute 1201 Pennsylvania Avenue Northwest, #400, Washington, DC, United States

Hudson Institute and the Bipartisan Commission on Biodefense will host a panel discussion on the ongoing coronavirus outbreak and how the United States can respond to the growing outbreak effectively. Confirmed infections of the coronavirus in China have exceeded that of the 2002-2003 SARS epidemic, with thousands more suspected cases. As the number of cases

CDC National Call Series on Novel Coronavirus Monitoring & Preparedness

The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national

The Novel Coronavirus: What Do We Know and What’s Next?

Neuroscience Research Building (NRB) 635 Charles E Young Drive South, Los Angeles, CA, United States

The UCLA Fielding School of Public Health and the UCLA Center for Chinese Studies present The Novel Coronavirus: What Do We Know and What's Next?, a symposium and reception. The novel coronavirus (2019-nCoV) was first reported in Wuhan, China in December 2019. On January 30, 2020, the WHO declared the outbreak a public health emergency of

WHO Global Research and Innovation Forum: 2019-nCoV Emergency

WHO Headquarters Geneva, Switzerland

The World Health Organization will host a Global research and innovation forum 11-12 February in Geneva to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency. The event is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R), and brings together key players including leading scientists as well as

Homeland Security & Governmental Affairs Committee: Protecting the U.S. from Global Pandemics

Dirksen Senate Office Building Washington, DC, United States

The U.S. Senate Committee on Homeland Security & Governemental Affairs will convene a Full Committee hearing on Feb.12 to examine protecting the United States from global pandemics. ROUNDTABLE: Are We Prepared? Protecting the U.S. from Global Pandemics will February 12, 2020 09:30 AM Location: SD-G50, Dirksen Senate Office Building The meeting will air on CSPAN. See

Deadline: CEPI Call for Proposals – Vaccines Against Novel Coronavirus

Global Biodefense Calendar

CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. The call is open for two weeks until mid-February. Applications are open worldwide to all types of non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and